{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T02:57:34Z","timestamp":1716001054603},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Supportive Cancer Therapy"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.3816\/sct.2005.n.006","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:12:34Z","timestamp":1221095554000},"page":"122-127","source":"Crossref","is-referenced-by-count":4,"title":["Single-Dose Prevention or Short-Term Treatment with Fibroblast Growth Factor-20 (CG53135-05) Reduces the Severity and Duration of Oral Mucositis"],"prefix":"10.3816","volume":"2","author":[{"given":"Enrique","family":"Alvarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie L.","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Gerwien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward G.","family":"Fey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brynmor A.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William F.","family":"Hahne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen T.","family":"Sonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/SCT.2005.n.006_bib1","first-page":"1767","article-title":"Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management","volume":"17","author":"Epstein","year":"2003","journal-title":"Oncology (Huntingt)"},{"issue":"9 suppl","key":"10.3816\/SCT.2005.n.006_bib2","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.20162","article-title":"Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients","volume":"100","author":"Sonis","year":"2004","journal-title":"Cancer"},{"key":"10.3816\/SCT.2005.n.006_bib3","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1046\/j.1440-1746.2003.03136.x","article-title":"Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer","volume":"18","author":"Gibson","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.3816\/SCT.2005.n.006_bib4","series-title":"Cancer Medicine. 5th ed","first-page":"2371","article-title":"Oral complications","author":"Sonis","year":"2000"},{"key":"10.3816\/SCT.2005.n.006_bib5","first-page":"391","article-title":"Effects of local application of amifostine (WR-1065) on epirubicine-induced oral mucositis. A phase II study","volume":"12","author":"Stokman","year":"2004","journal-title":"Support Care Cancer"},{"issue":"suppl 2","key":"10.3816\/SCT.2005.n.006_bib6","first-page":"73","article-title":"Use of recombinant human keratinocyte growth factor (palifermin) can reduce severe oral mucositis in patients with hematologic malignancies undergoing autologous peripheral blood progenitor cell transplantation after radiationbased conditioning","volume":"2","author":"Spielberger","year":"2004","journal-title":"J Support Oncol"},{"key":"10.3816\/SCT.2005.n.006_bib7","first-page":"2917","article-title":"Phase III study: AES-14 in patients at risk for mucositis secondary to anthracycline-based chemotherapy","volume":"22","author":"Peterson","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"9 suppl","key":"10.3816\/SCT.2005.n.006_bib8","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/cncr.20163","article-title":"Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis","volume":"100","author":"Rubenstein","year":"2004","journal-title":"Cancer"},{"key":"10.3816\/SCT.2005.n.006_bib9","series-title":"Tumor models in cancer research","article-title":"Animal models of oral mucositis induced by antineoplastic drugs and radiation","author":"Sonis","year":"2000"},{"key":"10.3816\/SCT.2005.n.006_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0964-1955(96)00043-7","article-title":"Transforming growth factorbeta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis","volume":"33","author":"Sonis","year":"1997","journal-title":"Oral Oncol"},{"key":"10.3816\/SCT.2005.n.006_bib11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1006\/cyto.1997.0208","article-title":"Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters","volume":"9","author":"Sonis","year":"1997","journal-title":"Cytokine"},{"key":"10.3816\/SCT.2005.n.006_bib12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0030-4220(90)90376-4","article-title":"An animal model for mucositis induced by cancer chemotherapy","volume":"69","author":"Sonis","year":"1990","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.3816\/SCT.2005.n.006_bib13","first-page":"3131","article-title":"Identification of a novel human fibroblast growth factor and characterization of its role in oncogenesis","volume":"61","author":"Jeffers","year":"2001","journal-title":"Cancer Res"},{"key":"10.3816\/SCT.2005.n.006_bib14","first-page":"3454","article-title":"Preclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy\/radiation-induced oral mucositis","volume":"9","author":"Alvarez","year":"2003","journal-title":"Clin Can Res"},{"key":"10.3816\/SCT.2005.n.006_bib15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1053\/gast.2002.36041","article-title":"A novel human fibroblast growth factor treats experimental intestinal inflammation","volume":"123","author":"Jeffers","year":"2002","journal-title":"Gastroenterology"},{"key":"10.3816\/SCT.2005.n.006_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc1318","article-title":"The pathobiology of mucositis","volume":"4","author":"Sonis","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"suppl 1","key":"10.3816\/SCT.2005.n.006_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2184.35.s1.10.x","article-title":"The gene expression sequence of radiated mucosa in an animal mucositis model","volume":"35","author":"Sonis","year":"2002","journal-title":"Cell Prolif"},{"key":"10.3816\/SCT.2005.n.006_bib18","unstructured":"Alvarez E, Narayanan B, MacLachlan T, et al. CG53135 (FGF-20) is a novel radioprotectant in vivo. Presented at: 95th Annual Meeting of the American Society of Cancer Research, March 27-31, 2004; Orlando, FL."},{"key":"10.3816\/SCT.2005.n.006_bib19","unstructured":"Alvarez E, Narayanan B, MacLachlan T, et al. Attributes and radioprotective properties of recombinant human recombinant fibroblast growth factor 20 (CG53135). Presented at the 51st Radiation Research Society Meeting; April 24-27, 2004; St. Louis, MO."},{"key":"10.3816\/SCT.2005.n.006_bib20","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1128\/MCB.22.15.5492-5505.2002","article-title":"Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound","volume":"22","author":"Braun","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.3816\/SCT.2005.n.006_bib21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1006\/abbi.1997.0237","article-title":"Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts","volume":"344","author":"Huang","year":"1997","journal-title":"Arch Biochem Biophys"},{"key":"10.3816\/SCT.2005.n.006_bib22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0891-5849(97)00291-8","article-title":"Role of antioxidant enzymes on ionizing radiation resistance","volume":"24","author":"Sun","year":"1998","journal-title":"Free Radic Biol Med"},{"key":"10.3816\/SCT.2005.n.006_bib23","first-page":"85","article-title":"Role of manganese superoxide dismutase in radioprotection using gene transfer studies","volume":"1","author":"Suresh","year":"1994","journal-title":"Cancer Gene Ther"}],"container-title":["Supportive Cancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543291213600478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543291213600478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T22:56:25Z","timestamp":1545778585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543291213600478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S1543291213600478"],"URL":"https:\/\/doi.org\/10.3816\/sct.2005.n.006","relation":{},"ISSN":["1543-2912"],"issn-type":[{"value":"1543-2912","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}